Invivoscribe Technologies and Thermo Fisher Scientific agreed to establish a long-term strategic alliance to develop multiple next-generation sequencing (NGS)-based, in vitro (in the lab) diagnostic (IVD) oncology tests, grounded on the Ion PGM Dx ... Read more